Found 230 results
2013
Brosius FC, Pennathur S.  2013.  How to find a prognostic biomarker for progressive diabetic nephropathy.. Kidney Int. 83(6):996-8.
Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, E Weil J, Cavalcoli JD, Patel JM, Brosius FC et al..  2013.  Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.. Diabetes. 62(1):299-308.
Brennan EP, Nolan KA, Börgeson E, Gough OS, McEvoy CM, Docherty NG, Higgins DF, Murphy M, Sadlier DM, Ali-Shah STasadaque et al..  2013.  Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.. J Am Soc Nephrol. 24(4):627-37.
Maitra D, Shaeib F, Abdulhamid I, Abdulridha RM, Saed GM, Diamond MP, Pennathur S, Abu-Soud HM.  2013.  Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.. Free Radic Biol Med. 63:90-8.
Brosius FC, Alpers CE.  2013.  New targets for treatment of diabetic nephropathy: what we have learned from animal models.. Curr Opin Nephrol Hypertens. 22(1):17-25.
Benito-Martin A, Ucero AConrado, Zubiri I, Posada-Ayala M, Fernandez-Fernandez B, Cannata-Ortiz P, Sanchez-Niño MDolores, Ruiz-Ortega M, Egido J, Alvarez-Llamas G et al..  2013.  Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.. PLoS One. 8(8):e72387.
Ren S, Duffield JS.  2013.  Pericytes in kidney fibrosis.. Curr Opin Nephrol Hypertens. 22(4):471-80.
Zhao W, Berthier CC, Lewis EE, W McCune J, Kretzler M, Kaplan MJ.  2013.  The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.. Clin Immunol. 149(1):119-32.
Jiang S, Chuang PY, Liu Z-H, He JC.  2013.  The primary glomerulonephritides: a systems biology approach.. Nat Rev Nephrol. 9(9):500-12.
Eksi R, Li H-D, Menon R, Wen Y, Omenn GS, Kretzler M, Guan Y.  2013.  Systematically differentiating functions for alternatively spliced isoforms through integrating RNA-seq data.. PLoS Comput Biol. 9(11):e1003314.
Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS.  2013.  Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.. PLoS One. 8(3):e57751.
Deshpande SD, Putta S, Wang M, Lai JY, Bitzer M, Nelson RG, Lanting LL, Kato M, Natarajan R.  2013.  Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.. Diabetes. 62(9):3151-62.
Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M et al..  2013.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.. J Am Soc Nephrol. 24(12):2081-95.
2012
Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC.  2012.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.. Kidney Int. 81(1):40-55.
Jim B, Santos J, Spath F, He JCijiang.  2012.  Biomarkers of diabetic nephropathy, the present and the future.. Curr Diabetes Rev. 8(5):317-28.
O'Donovan HC, Hickey F, Brazil DP, Kavanagh DH, Oliver N, Martin F, Godson C, Crean J.  2012.  Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.. Biochem J. 441(1):499-510.
Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, Böttinger EP, Segerer S, Lindenmeyer M, Cohen CD et al..  2012.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.. J Immunol. 189(2):988-1001.
Keller BJ, Eichinger F, Kretzler M.  2012.  Formal concept analysis of disease similarity.. AMIA Jt Summits Transl Sci Proc. 2012:42-51.
Berthier CC, Kretzler M, Davidson A.  2012.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.. J Data Mining Genomics Proteomics. 3(3)
Ju W, Smith S, Kretzler M.  2012.  Genomic biomarkers for chronic kidney disease.. Transl Res. 159(4):290-302.
Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D et al..  2012.  Growth-dependent podocyte failure causes glomerulosclerosis.. J Am Soc Nephrol. 23(8):1351-63.
Boucher I, Yu W, Beaudry S, Negoro H, Tran M, Pollak MR, Henderson JM, Denker BM.  2012.  Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.. Lab Invest. 92(5):662-75.
Conway BR, Rennie J, Bailey MA, Dunbar DR, Manning JR, Bellamy CO, Hughes J, Mullins JJ.  2012.  Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.. J Am Soc Nephrol. 23(3):405-11.
El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M et al..  2012.  Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.. BMC Nephrol. 13:61.
Klein J, Jupp S, Moulos P, Fernandez M, Buffin-Meyer B, Casemayou A, Chaaya R, Charonis A, Bascands J-L, Stevens R et al..  2012.  The KUPKB: a novel Web application to access multiomics data on kidney disease.. FASEB J. 26(5):2145-53.

Pages